Sarah Cannon Research Institute · 6 days ago
Accounts Receivable Analyst - Remote US
Sarah Cannon Research Institute (SCRI) is a leading oncology research organization focused on advancing therapies for cancer patients. The Accounts Receivable Analyst is responsible for the collection of client receivables, maintaining relationships with sponsors, and resolving disputes related to payments.
Responsibilities
Monitor assigned accounts: review aging, look for irregularities, non-payments, and delayed payments in customer accounts
Contact Sponsors/CROs via phone to follow on unpaid/open invoices and ensure timely payments are received
Investigate and resolve sponsor, patient and customer disputes
Maintaining a strong business relationship with the Sponsors/CROs as the primary contact and voice for Sarah Cannon Research Institute in regards to payment of receivables
Reconcile financial study data with data provided by Sponsors/CROs as needed
Review, interpret and discuss contracts internally and with clients to assist with resolving payment or dispute issues
Review medical procedure invoices in relation to the contracts to determine eligibility for reimbursement of costs
Identify, report on and work with supervisor to resolve trends that negatively impact payment or workflows
Work with other departments (i.e. Accounting, Treasury, Contracting) to resolve billing questions as needed
Other duties as assigned
Qualification
Required
1+ year work experience reading and comprehending complex documents and identify financial impacts
Understanding of clinical financial systems and EMRs
Preferred
Bachelor's Degree preferred, experience may be substituted for education
Clinical Research experience highly preferred
Benefits
Comprehensive benefits to support physical, mental, and financial well-being
Competitive compensation package
Annual bonus
Long-term incentive opportunities
Company
Sarah Cannon Research Institute
Sarah Cannon Research Institute is one of the world’s leading oncology research organizations conducting community-based clinical trials.
Funding
Current Stage
Late StageRecent News
Company data provided by crunchbase